From R&D to ROI: How Outsourced Accounting Fuels Biotech Innovation
Unlock biotech innovation potential with outsourced accounting. Transform R&D investments into ROI drivers. Streamline financial
Accounting for life sciences companies, along with their financial management, is complex and dynamic due to the nature of the industry. Unlike other industries, life sciences and biotechnology companies face long research and development cycles, often with lean back-office teams, making it essential to maximize operational efficiencies and streamline processes. Furthermore, biotechnology accounting has specific regulations and compliance requirements, with outside investors and venture capital playing a significant role.
Our team of experts understands the industry’s complex and often unpredictable nature and can provide the financial insight and support you need to succeed. Whether you are developing new pharmaceuticals, medical equipment, or gene therapies, we can provide a complete suite of biotechnology accounting, finance, and tax services to help you streamline your processes and increase operational efficiencies. By partnering with Scrubbed, life sciences and biotechnology companies can benefit from the flexibility, scalability, and cost-effectiveness of outsourcing, and focus on their core business of advancing scientific innovation.
At Scrubbed, we leverage our specialized knowledge and experience to help life sciences and biotechnology companies with the accounting and financial services they need. We understand the complex compliance requirements specific to your industry and can help you run efficiently. Whether you have a CFO who needs support or prefers to outsource your entire biotechnology accounting and finance function, we have the team to deliver the reporting and advice you require to make informed business decisions.
Analyze financial instruments and assess expected credit loss model in accordance with ASC 326/IFRS 9
Analyze lease contracts analysis in accordance with ASC 842/IFRS 16
Assist in adoption of other complex emerging standards
Conduct an audit readiness program – planning, execution, and completion
Facilitate Financial Statement conversions between accounting frameworks (e.g. Local GAAP to US GAAP, IFRS to US GAAP, and vice versa)
Conduct an IPO readiness program
Account and report impact of significant unusual transactions
Support in transaction structure, including contract consultancy (acquisitions and readiness)
Assess ESG preparedness in terms of dealing with GHG emissions, value chain and other stakeholder concerns.
Account and report ESG-related assets and transactions.
Establish ESG policies and procedures in compliance with sustainability standards.
“Scrubbed matched up with everything Rejuvenation
Technologies was looking for in an outsourced accounting
partner,” said Director of Finance and Administration Robin Holbrook.
“Scrubbed matched up with everything Rejuvenation
Technologies was looking for in an outsourced accounting
partner,” said Director of Finance and Administration Robin Holbrook.
Innovate with Confidence:
Outsource Your Financial Tasks to Scrubbed, Your Dedicated Partner in the Biotech Industry
We understand that staying on top of financial reporting and tax strategy is essential for your success, and we’re committed to creating operational efficiencies that will help your company thrive. We work with you to become a vital part of your team, adapting to your needs and providing the information you need to keep stakeholders confident in your work. And as you move from R&D to market, our experienced professionals can help you evolve and maximize your potential for success
Unlock biotech innovation potential with outsourced accounting. Transform R&D investments into ROI drivers. Streamline financial
Explore ASC 606’s guidance in Biotech revenue recognition. Come join us as we unravel the
Unlock biotech success with streamlined account and financial processes. Our solutions simplify complexities, fostering growth.
Learn the five crucial steps to reduce accounting and financial reporting risks in the biotech
Kevin has more than 10 years of professional experience focusing on general and real estate accounting, budget and cash flow analyses, and financial modeling. His expertise is on business process optimization, systems migration, and developing reasonable business policies. He is adept at utilizing multiple reporting software and other SaaS interfaces. He currently manages a mixture of Real Estate and Biotechnology groups in Scrubbed. Prior to Scrubbed, he worked at the Fraud, Claims, and Disputes Unit of JPMorgan Chase & Co.
Want to learn more? Let’s chat about how we can help by managing your day-to-day accounting needs, or taking on a larger financial management role, so you can continue to deliver on your mission-critical goals.
Want to learn more? Let’s chat about how we can help by managing your day-to-day accounting needs, or taking on a larger financial management role, so you can continue to deliver on your mission-critical goals.